ETrade Capital Management’s Zimmer Biomet ZBH Stock Holding History

ETrade Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$203K	Sell	1,533 -793	-34%	-$104K	﹤0.01%	820
2020 Q2	$270K	Sell	2,326 -3,526	-60%	-$406K	0.01%	693
2020 Q1	$574K	Sell	5,852 -1,398	-19%	-$183K	0.01%	435
2019 Q4	$1.05M	Buy	7,250 +1,715	+31%	+$237K	0.02%	353
2019 Q3	$737K	Buy	5,535 +2,708	+96%	+$350K	0.02%	433
2019 Q2	$323K	Buy	+2,827	New	+$331K	0.01%	665
2019 Q1	–	Sell	-1,986	Closed	-$200K	–	862
2018 Q4	$200K	Sell	1,986 -1,921	-49%	-$216K	0.01%	719
2018 Q3	$499K	Buy	3,907 +199	+5%	+$23.7K	0.01%	552
2018 Q2	$401K	Buy	3,708 +1,390	+60%	+$151K	0.01%	579
2018 Q1	$245K	Buy	+2,318	New	+$269K	0.01%	679

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ETrade Capital Management's ZBH Position: Q3 2020 in Review

ETrade Capital Management reduced its Zimmer Biomet (ZBH) stake by 34% in Q3 2020, selling an estimated $104K and leaving 1,533 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #820.

ETrade Capital Management first reported a position in ZBH in Q1 2018 and has held it in 10 quarters since. The position peaked at $1.05M in Q4 2019. 931 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

ETrade Capital Management held 1,533 shares of Zimmer Biomet worth $203K as of Q3 2020.
ETrade Capital Management sold 793 Zimmer Biomet shares in Q3 2020, an estimated $104K.
Zimmer Biomet made up ﹤0.01% of ETrade Capital Management's portfolio in Q3 2020, its #820 holding.
ETrade Capital Management first reported a position in Zimmer Biomet in Q1 2018 and has held it in 10 quarters since.
ETrade Capital Management's Zimmer Biomet position peaked at $1.05M in Q4 2019.
931 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.